cladribine has been researched along with Agnogenic Myeloid Metaplasia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahm, AEA; Dybedal, I; Habberstad, AH; Randen, U; Spetalen, S; Tjønnfjord, GE; Tran, HTT | 1 |
| Dedic, K; Zák, P | 2 |
| Araki, H; Kuribayashi, K; Kuroda, H; Matsunaga, T; Murase, K; Niitsu, Y; Terui, T | 1 |
| Faoro, LN; Mesa, RA; Tefferi, A | 1 |
| Fenk, R; Gattermann, N; Germing, U; Haas, R; Kündgen, A; Strupp, C | 1 |
| Li, CY; Silverstein, MN; Tefferi, A | 1 |
| Abramson, N; Marks, AR | 1 |
| Reilly, JT | 1 |
1 review(s) available for cladribine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Pathogenesis and management of idiopathic myelofibrosis.
Topics: Anemia; Animals; Bone Marrow; Bone Marrow Transplantation; Cladribine; Combined Modality Therapy; Disease Models, Animal; Erythropoietin; Growth Substances; Hematopoietic Stem Cells; Humans; Hydroxyurea; Interferon-alpha; Karyotyping; Megakaryocytes; Mice; Polyethylene Glycols; Primary Myelofibrosis; Prognosis; Recombinant Proteins; Splenectomy; Stromal Cells; Thrombopoietin; Vitamin D | 1998 |
8 other study(ies) available for cladribine and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Marrow; Cladribine; Disease Progression; Fatal Outcome; Humans; Janus Kinase 2; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukopenia; Male; Neutropenia; Oral Ulcer; Polycythemia Vera; Primary Myelofibrosis; Splenomegaly; Thrombocytopenia | 2018 |
Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Primary Myelofibrosis | 2004 |
[Bone marrow fibrosis during therapy of hairy cell leukemia].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Primary Myelofibrosis | 2004 |
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Topics: Antineoplastic Agents; Cladribine; Drug Administration Schedule; Erythema Nodosum; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Pancytopenia; Primary Myelofibrosis; Remission Induction; Splenomegaly | 2004 |
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Hematologic Diseases; Hepatomegaly; Humans; Male; Middle Aged; Palliative Care; Primary Myelofibrosis; Retrospective Studies; Splenectomy | 2005 |
Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
Topics: Aged; Cladribine; Humans; Leukemia, Hairy Cell; Male; Primary Myelofibrosis; Remission Induction; Thalidomide; Treatment Outcome | 2005 |
2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia.
Topics: Anemia; Cladribine; Female; Follow-Up Studies; Hepatomegaly; Humans; Leukocytosis; Male; Primary Myelofibrosis; Splenectomy; Thrombocytosis; Treatment Outcome | 1997 |
Effect of 2-CDA on thrombocytopenia in myelofibrosis.
Topics: Cladribine; Humans; Immunosuppressive Agents; Primary Myelofibrosis; Thrombocytopenia | 1998 |